Morning Overview on MSN
Scientists finally uncover what went wrong with J&J’s COVID vaccine
When reports of rare but severe blood clots emerged after Johnson & Johnson’s COVID vaccine, they threatened to overshadow an otherwise successful immunization campaign and left scientists searching ...
A new vaccine design uses folded DNA to steer the immune system toward producing the rare immune cells needed to make ...
After years of sleuthing, Australian researchers believe they have cracked the cause of lethal blood clots caused in rare cases by AstraZeneca’s COVID vaccine – and how to beat the problem.
People in Canada have a new, less invasive way to test for HIV at home, following Health Canada's approval of an oral ...
Plano’s Amber Glenn didn’t get the chance to try to qualify for the 2022 U.S. team because she tested positive for COVID-19.
A Swedish registry-based cohort study evaluated whether COVID-19 vaccination affected childbirth rates among women aged 18 to ...
SHELTON, CONNECTICUT / ACCESS Newswire / February 2, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a ...
Kirin Holdings Company, Limited (Kirin Holdings) and Immunosens Co., Ltd. (Immunosens) have begun the joint development of a ...
Blood tests revealed that the beverage elicited an immune response, according to preliminary research. But far more safety ...
Pfizer (PFE) stock hold rating: 2026 patent cliff, falling Covid sales, GLP-1 obesity timeline, and M&A integration risks—read the outlook now.
“Expanding access to HIV testing options is a critical component in the global effort to end the HIV epidemic,” said Carrie Eglinton Manner, President and CEO of OraSure, in a news release. “Early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results